Entering text into the input field will update the search result below

FDA OKs Mylan's generic version of Biogen MS med Tecfidera

Aug. 18, 2020 3:36 PM ETViatris Inc. (VTRS) Stock, BIIB StockBIIB, VTRSBy: Douglas W. House, SA News Editor7 Comments
  • The FDA has approved Mylan's (MYL -0.6%) generic version of Biogen's (BIIB -0.3%) top seller Tecfidera (dimethyl fumarate).
  • The agency signed off on the application after a federal judge in West Virginia invalidated a patent on the multiple sclerosis drug. Biogen intends to appeal the decision.
  • Tecfidera accounted for 32% of Biogen's Q2 revenue ($1,182M/3,682M).

Recommended For You

Related Stocks

SymbolLast Price% Chg
BIIB
--
VTRS
--